Stem cells show promising results for lymphoedema treatment – A literature review

References

• Dupuy A, Benchikhi H, Roujeau JC, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 1999;318:1591–4.
   PubMed Web of Science ®Google Scholar
• Soo JK, Bicanic TA, Heenan S, Mortimer PS. Lymphatic abnormalities demonstrated by lymphoscintigraphy after lower limb cellulitis. Br J Dermatol 2008;158:1350–3.
   Google Scholar
• McWayne J, Heiney SP. Psychologic and social sequelae of secondary lymphedema: a review. Cancer 2005;104:457–66.
   PubMed Web of Science ®Google Scholar
• Tobin MB, Lacey HJ, Meyer L, Mortimer PS. The psychological morbidity of breast cancer-related arm swelling. Psychological morbidity of lymphoedema. Cancer 1993;72:3248–52.
   PubMed Web of Science ®Google Scholar
• Woodward AH, Ivins JC, Soule EH. Lymphangiosarcoma arising in chronic lymphedematous extremities. Cancer 1972;30:562–72.
   PubMedGoogle Scholar
• Tomita K, Yokogawa A, Oda Y, Terahata S. Lymphangiosarcoma in postmastectomy lymphedema (Stewart-Treves syndrome): ultrastructural and immunohistologic characteristics. J Surg Oncol 1988;38:275–82.
   PubMedGoogle Scholar
• Smeltzer DM, Stickler GB, Schirger A. Primary lymphedema in children and adolescents: a follow-up study and review. Pediatrics 1985;76:206–18.
   PubMed Web of Science ®Google Scholar
• DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 2013;14:500–15.
   PubMed Web of Science ®Google Scholar
• Clark B, Sitzia J, Harlow W. Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study. QJM 2005;98:343–8.
   PubMed Web of Science ®Google Scholar
• Campisi C, Bellini C, Campisi C, et al. Microsurgery for lymphedema: clinical research and long-term results. Microsurgery 2010;30:256–60.
   PubMed Web of Science ®Google Scholar
• Rockson SG. Update on the biology and treatment of lymphedema. Curr Treat Options Cardiovasc Med 2012;14:184–92.
   Google Scholar
• Mizuno H. Adipose-derived stem cells for tissue repair and regeneration: ten years of research and a literature review. J Nippon Med Sch 2009;76:56–66.
   PubMedGoogle Scholar
• Hanson SE, Bentz ML, Hematti P. Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg 2010;125:510–16.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315–17.
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211–28.
   PubMedGoogle Scholar
• The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 2013;46:1–11.
   PubMed Web of Science ®Google Scholar
• Ko DS, Lerner R, Klose G, Cosimi AB. Effective treatment of lymphedema of the extremities. Arch Surg 1998;133:452–8.
   PubMedGoogle Scholar
• Boris M, Weindorf S, Lasinkski S. Persistence of lymphedema reduction after noninvasive complex lymphedema therapy. Oncology (Williston Park) 1997;11:99–109; discussion 110, 113–4.
   Google Scholar
• Lasinski BB, McKillip Thrift K, Squire D, et al. A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM R 2012;4:580–601.
   PubMedGoogle Scholar
• Ogunbiyi SO, Modarai B, Smith A, Burnand KG. Quality of life after surgical reduction for severe primary lymphoedema of the limbs and genitalia. Br J Surg 2009;96:1274–9.
   Google Scholar
• Tiwari A, Cheng K-S, Button M, et al. Differential diagnosis, investigation, and current treatment of lower limb lymphedema. Arch Surg 2003;138:152–61.
   PubMedGoogle Scholar
• Brorson H, Ohlin K, Olsson G, et al. Controlled compression and liposuction treatment for lower extremity lymphedema. Lymphology 2008;41:52–63.
   PubMed Web of Science ®Google Scholar
• Lin C-H, Ali R, Chen S-C, et al. Vascularized groin lymph node transfer using the wrist as a recipient site for management of postmastectomy upper extremity lymphedema. Plast Reconstr Surg 2009;123:1265–75.
   PubMed Web of Science ®Google Scholar
• Becker C, Assouad J, Riquet M, Hidden G. Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation. Ann Surg 2006;243:313–15.
   PubMed Web of Science ®Google Scholar
• Saaristo AM, Niemi TS, Viitanen TP, et al. Microvascular breast reconstruction and lymph node transfer for postmastectomy lymphedema patients. Ann Surg 2012;255:468–73.
   Google Scholar
• Chang DW. Lymphaticovenular bypass for lymphedema management in breast cancer patients: a prospective study. Plast Reconstr Surg 2010;126:752–8.
   PubMed Web of Science ®Google Scholar
• Damstra RJ, Voesten HGJ, van Schelven WD, van der Lei B. Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature. Breast Cancer Res Treat 2009;113:199–206.
   PubMed Web of Science ®Google Scholar
• Penha TRL, Ijsbrandy C, Hendrix NAM, et al. Microsurgical techniques for the treatment of breast cancer-related lymphedema: a systematic review. J Reconstr Microsurg 2013;29:99–106.
   Google Scholar
• Cowan CM, Shi Y-Y, Aalami OO, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004;22:560–7.
   PubMed Web of Science ®Google Scholar
• Rubin JP, Bennett JM, Doctor JS, et al. Collagenous microbeads as a scaffold for tissue engineering with adipose-derived stem cells. Plast Reconstr Surg 2007;120:414–24.
   PubMed Web of Science ®Google Scholar
• Strem BM, Hicok KC, Zhu M, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med 2005;54:132–41.
   PubMed Web of Science ®Google Scholar
• Wei Y, Hu Y, Lv R, Li D. Regulation of adipose-derived adult stem cells differentiating into chondrocytes with the use of rhBMP-2. Cytotherapy 2006;8:570–9.
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279–95.
   PubMed Web of Science ®Google Scholar
• Ferroni L, Gardin C, Tocco I, et al. Potential for neural differentiation of mesenchymal stem cells. Adv Biochem Eng Biotechnol 2013;129:89–115.
   PubMed Web of Science ®Google Scholar
• Baer PC. Adipose-derived stem cells and their potential to differentiate into the epithelial lineage. Stem Cells Dev 2011;20:1805–16.
   PubMed Web of Science ®Google Scholar
• Mizuno H, Tobita M, Uysal AC. Concise review: adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 2012;30:804–10.
   PubMed Web of Science ®Google Scholar
• Fraser JK, Wulur I, Alfonso Z, Hedrick MH. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol 2006;24:150–4.
   PubMed Web of Science ®Google Scholar
• Gimble JM. Adipose tissue-derived therapeutics. Expert Opin Biol Ther 2003;3:705–13.
   PubMed Web of Science ®Google Scholar
• Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007;100:1249–60.
   PubMed Web of Science ®Google Scholar
• Lin K, Matsubara Y, Masuda Y, et al. Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy 2008;10:417–26.
   PubMed Web of Science ®Google Scholar
• Girard A-C, Atlan M, Bencharif K, et al. New insights into lidocaine and adrenaline effects on human adipose stem cells. Aesthetic Plast Surg 2013;37:144–52.
   Google Scholar
• Keck M, Janke J, Ueberreiter K. Viability of preadipocytes in vitro: the influence of local anesthetics and pH. Dermatol Surg 2009;35:1251–7.
   Google Scholar
• Keck M, Zeyda M, Gollinger K, et al. Local anesthetics have a major impact on viability of preadipocytes and their differentiation into adipocytes. Plast Reconstr Surg 2010;126:1500–5.
   Google Scholar
• Shoshani O, Berger J, Fodor L, et al. The effect of lidocaine and adrenaline on the viability of injected adipose tissue–an experimental study in nude mice. J Drugs Dermatol 2005;4:311–16.
   Google Scholar
• Buttler K, Badar M, Seiffart V, et al. De novo hem- and lymphangiogenesis by endothelial progenitor and mesenchymal stem cells in immunocompetent mice. Cell Mol Life Sci 2014;71:1513–27.
   Google Scholar
• Jackson DG. The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc Med 2003;13:1–7.
   PubMed Web of Science ®Google Scholar
• Wilting J, Papoutsi M, Christ B, et al. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues. FASEB J 2002;16:1271–3.
   PubMed Web of Science ®Google Scholar
• Kato S, Shimoda H, Ji R-C, Miura M. Lymphangiogenesis and expression of specific molecules as lymphatic endothelial cell markers. Anat Sci Int 2006;81:71–83.
   Google Scholar
• Jussila L, Alitalo K. Vascular growth factors and lymphangiogenesis. Physiol Rev 2002;82:673–700.
   PubMed Web of Science ®Google Scholar
• Kajiya K, Hirakawa S, Ma B, et al. Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J 2005;24:2885–95.
   PubMedGoogle Scholar
• Saito Y, Nakagami H, Morishita R, et al. Transfection of human hepatocyte growth factor gene ameliorates secondary lymphedema via promotion of lymphangiogenesis. Circulation 2006;114:1177–84.
   Google Scholar
• Cai L, Johnstone BH, Cook TG, et al. Suppression of hepatocyte growth factor production impairs the ability of adipose-derived stem cells to promote ischemic tissue revascularization. Stem Cells 2007;25:3234–43.
   PubMed Web of Science ®Google Scholar
• Ebrahimian TG, Pouzoulet F, Squiban C, et al. Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol 2009;29:503–10.
   PubMed Web of Science ®Google Scholar
• Nie C, Yang D, Xu J, et al. Locally administered adipose-derived stem cells accelerate wound healing through differentiation and vasculogenesis. Cell Transplant 2011;20:205–16.
   PubMed Web of Science ®Google Scholar
• Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 2004;109:1292–8.
   PubMed Web of Science ®Google Scholar
• Kim W-S, Park B-S, Sung J-H. The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther 2009;9:879–87.
   PubMed Web of Science ®Google Scholar
• Chung JY, Kim W, Im W, et al. Neuroprotective effects of adipose-derived stem cells against ischemic neuronal damage in the rabbit spinal cord. J Neurol Sci 2012;317:40–6.
   Google Scholar
• Zhang H, Yang R, Wang Z, et al. Adipose tissue-derived stem cells secrete CXCL5 cytokine with neurotrophic effects on cavernous nerve regeneration. J Sex Med 2011;8:437–46.
   PubMed Web of Science ®Google Scholar
• Fang B, Mai L, Li N, Song Y. Favorable response of chronic refractory immune thrombocytopenic purpura to mesenchymal stem cells. Stem Cells Dev 2012;21:497–502.
   Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.
   PubMed Web of Science ®Google Scholar
• Conrad C, Niess H, Huss R, et al. Multipotent mesenchymal stem cells acquire a lymphendothelial phenotype and enhance lymphatic regeneration in vivo. Circulation 2009;119:281–9.
   PubMed Web of Science ®Google Scholar
• Shimizu Y, Shibata R, Shintani S, et al. Therapeutic lymphangiogenesis with implantation of adipose-derived regenerative cells. J Am Heart Assoc 2012;1:e000877.
   Google Scholar
• Hwang JH, Kim IG, Lee JY, et al. Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel. Biomaterials 2011;32:4415–23.
   PubMed Web of Science ®Google Scholar
• Park HS, Jung IM, Choi GH, et al. Modification of a rodent hindlimb model of secondary lymphedema: surgical radicality versus radiotherapeutic ablation. Biomed Res Int 2013;2013:208912.
   Google Scholar
• Zhou H, Wang M, Hou C, et al. Exogenous VEGF-C augments the efficacy of therapeutic lymphangiogenesis induced by allogenic bone marrow stromal cells in a rabbit model of limb secondary lymphedema. Jpn J Clin Oncol 2011;41:841–6.
   Google Scholar
• Maldonado GEM, Pérez CAA, Covarrubias EEA, et al. Autologous stem cells for the treatment of post–mastectomy lymphedema: a pilot study. Cytotherapy 2011;13:1249–55.
   Web of Science ®Google Scholar
• Hou C, Wu X, Jin X. Autologous bone marrow stromal cells transplantation for the treatment of secondary arm lymphedema: a prospective controlled study in patients with breast cancer related lymphedema. Jpn J Clin Oncol 2008;38:670–4.
   Google Scholar
• Gimble JM, Bunnell BA, Chiu ES, Guilak F. Concise review: adipose-derived stromal vascular fraction cells and stem cells: let’s not get lost in translation. Stem Cells 2011;29:749–54.
   PubMed Web of Science ®Google Scholar